Cover Image
市場調查報告書

人工心臟瓣膜的全球市場的預測 ∼2022年:各類型 (經導管瓣膜、生物學心臟瓣膜、機械瓣膜)、地區

Prosthetic Heart Valve/ Artificial Heart Valve Market by Type (Transcatheter Heart Valve, Tissue Heart Valve, and Mechanical Heart Valve), and Region (North America, Europe, Asia-Pacific, and RoW) - Global Forecast to 2022

出版商 MarketsandMarkets 商品編碼 352646
出版日期 內容資訊 英文 159 Pages
訂單完成後即時交付
價格
Back to Top
人工心臟瓣膜的全球市場的預測 ∼2022年:各類型 (經導管瓣膜、生物學心臟瓣膜、機械瓣膜)、地區 Prosthetic Heart Valve/ Artificial Heart Valve Market by Type (Transcatheter Heart Valve, Tissue Heart Valve, and Mechanical Heart Valve), and Region (North America, Europe, Asia-Pacific, and RoW) - Global Forecast to 2022
出版日期: 2017年06月05日 內容資訊: 英文 159 Pages
簡介

全球人工心臟瓣膜的市場預計從2017年到2022年以12.9%的年複合成長率發展,2022年成長到88億6000萬美元的規模。老年人口的增加與其伴隨的HVD盛行率的擴大,新的先進產品的認證,政府對心臟瓣膜研究的資金供給的擴大,HVD的認識度提高,有利的償付方案等要素促進該市場的成長。

本報告提供全球人工心臟瓣膜的市場調查,市場及產品概要,影響市場成長因素及市場機會分析,各類型、地區/主要國家趨勢與市場規模的變化與預測,競爭環境與市場佔有率,以及主要企業的簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 簡介
  • 市場成果、預測:各類型
  • 地區概要

第5章 市場概要

  • 簡介
  • 市場動態
    • 推動因素
    • 阻礙因素
    • 市場機會
    • 課題

第6章 市場分析:各閥類型

  • 簡介
  • 經導管心臟瓣膜
  • 生物心臟瓣膜
  • 機器心臟瓣膜

第7章 市場分析:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 其他
  • 其他地區

第8章 競爭環境

  • 市場佔有率分析
    • 簡介
    • 企業佔有率:經導管心臟瓣膜
    • 企業佔有率:生物心臟瓣膜
    • 企業佔有率:機器心臟瓣膜
    • EDWARDS LIFESCIENCES CORPORATION
    • MEDTRONIC PLC
    • ST. JUDE MEDICAL, INC.
  • VENDOR DIVE:概要
  • 競爭基準
    • 主要企業的產品系列
    • 主要企業的產業策略

第9章 企業簡介

  • 簡介
  • MEDTRONIC PLC
  • EDWARDS LIFESCIENCES CORPORATION
  • BOSTON SCIENTIFIC CORPORATION
  • LIVANOVA PLC
  • ST. JUDE MEDICAL, INC.
  • SYMETIS SA
  • JENAVALVE TECHNOLOGY, INC.
  • CRYOLIFE, INC.
  • TTK HEALTHCARE LIMITED
  • COLIBRI HEART VALVE, LLC
  • LEPU MEDICAL TECHNOLOGY CO., LTD.
  • BRAILE BIOMEDICA

第10章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MD 4094

"Prosthetic Heart Valves Market Projected to Grow at a CAGR of 12.9% in the Forecast Period (2017 to 2022)"

The prosthetic heart valves market is projected to reach USD 8.86 billion by 2022, at a CAGR of 12.9% from 2017 to 2022. The major factors driving the growth of this market include the rising geriatric population and the subsequent increase in the prevalence of HVD, regulatory approvals for new and advanced prosthetic heart valves, increasing government funding for heart valve research, rising awareness about HVD, and favorable reimbursement scenario for prosthetic heart valves.

"Transcatheter Heart Valves to Register the Highest CAGR During the Forecast Period"

Based on the type of valve, the prosthetic heart valves market is categorized as transcatheter heart valves, tissue heart valves, and mechanical heart valves. The transcatheter heart valves segment is expected to register the highest CAGR during the forecasting period. Factors such as the rising prevalence of aortic stenosis, increasing pool of patients owing to approvals for extended valve indications, and technological advancements are supporting the growth of this segment.

"North America Is Estimated to Be the Fastest-growing Regional Segment in the Global Prosthetic Heart Valves Market During the Forecast Period"

In 2017, North America is expected to dominate the prosthetic heart valves market, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). This regional segment is also projected to register the highest CAGR during the forecast period. Factors such as the rapid growth in the aging population and prevalence of valvular heart diseases, favorable reimbursement scenario, and rising product approvals for heart valves are contributing to the growth of the North American prosthetic heart valves market.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1: 52%, Tier 2: 30%, Tier 3: 18%
  • By Designation: Director-level: 43%, C-level: 36%, Others: 21%
  • By Region: North America: 43%, Europe: 23%, APAC: 20%, RoW: 14%

The key players in this market are Medtronic plc (Ireland), Edwards Lifesciences Corporation (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (Abbott Laboratories Company) (U.S.), LivaNova PLC (U.K.), Symetis SA (Switzerland), Jenavalve Technology, Inc. (Germany), CryoLife, Inc. (U.S.), TTK Healthcare Limited (India), Colibri Heart Valve, LLC (U.S.), Lepu Medical Technology Co., Ltd. (China), and Braile Biomedica (Brazil).

Research Coverage:

The report analyses the prosthetic heart valves market by type of valve and region. Apart from comprehensive geographic analysis, market sizing and volume analysis, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. The company profiles section in the report comprises the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The above-mentioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful in the market.

Reasons for buying the report:

The report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps firms to garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) to strengthen their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the products offered by the top players in the prosthetic heart valves market. The report analyzes the prosthetic heart valves market by type of valve
  • Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and product launches in the prosthetic heart valves market
  • Market Development: Comprehensive information about lucrative emerging markets.
  • Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the prosthetic heart valves market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, and distribution networks of the leading players in the prosthetic heart valves market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH METHODOLOGY STEPS
  • 2.2. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
    • 2.2.1. SECONDARY RESEARCH
    • 2.2.2. PRIMARY RESEARCH
      • 2.2.2.1. Key industry insights
      • 2.2.2.2. Key data from primary sources
      • 2.2.2.3. Key insights from primary sources
  • 2.3. MARKET SIZE ESTIMATION METHODOLOGY
  • 2.4. RESEARCH DESIGN
  • 2.5. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.6. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. INTRODUCTION
  • 4.2. GLOBAL PROSTHETIC HEART VALVES MARKET, BY TYPE OF VALVE, 2017 VS. 2022
  • 4.3. GEOGRAPHICAL SNAPSHOT OF GLOBAL PROSTHETIC HEART VALVES MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Rising geriatric population and subsequent growth in prevalence of heart valve disease
      • 5.2.1.2. Regulatory approvals for new and advanced prosthetic heart valves
        • 5.2.1.2.1. Product approvals for Medtronic plc:
        • 5.2.1.2.2. Product approvals for Edward Lifesciences Corporation:
        • 5.2.1.2.3. Product approvals for Boston Scientific Corporation:
        • 5.2.1.2.4. Product approvals for Livanova PLC:
        • 5.2.1.2.5. Product approvals for St. Jude Medical, Inc.:
        • 5.2.1.2.6. Product approvals for other companies:
      • 5.2.1.3. Increasing government funding for heart valve research
      • 5.2.1.4. Rising awareness about heart valve diseases
      • 5.2.1.5. Favorable reimbursement scenario for prosthetic heart valves
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. High cost of transcatheter aortic valve replacement (TAVR) procedures
      • 5.2.2.2. Availability of alternative methods for treating heart valve diseases (HVD)
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Expanding indication of TAVR from only high-risk to intermediate- or low-risk patients
      • 5.2.3.2. Strong product pipeline
      • 5.2.3.3. Increasing investments by key players in startup companies
      • 5.2.3.4. Growth potential offered by emerging countries
    • 5.2.4. CHALLENGE
      • 5.2.4.1. Emergence of tissue-engineered heart valves (TEHV)

6. GLOBAL PROSTHETIC HEART VALVE MARKET, BY TYPE OF VALVE

  • 6.1. INTRODUCTION
  • 6.2. TRANSCATHETER HEART VALVES
  • 6.3. TISSUE HEART VALVES
  • 6.4. MECHANICAL HEART VALVES

7. GLOBAL PROSTHETIC HEART VALVE MARKET, BY REGION

  • 7.1. INTRODUCTION
  • 7.2. NORTH AMERICA
    • 7.2.1. U.S.
      • 7.2.1.1. Rapid growth in the aging population and prevalence of valvular heart diseases
      • 7.2.1.2. Rising preference for transcatheter aortic valve replacement (TAVR)
      • 7.2.1.3. Favorable reimbursement scenario for prosthetic heart valves
      • 7.2.1.4. Initiatives to increase awareness of valvular heart diseases (VHD)
      • 7.2.1.5. Stringent regulations for new prosthetic heart valve approval
    • 7.2.2. CANADA
      • 7.2.2.1. Favorable reimbursement and funding
      • 7.2.2.2. Rising approvals for heart valves
  • 7.3. EUROPE
    • 7.3.1. INCREASING AGING POPULATION AND VALVULAR HEART DISEASES (VHD) PREVALENCE
    • 7.3.2. GROWTH IN THE NUMBER OF RESEARCH ACTIVITIES
    • 7.3.3. GERMANY
      • 7.3.3.1. Favorable reimbursement policies
    • 7.3.4. FRANCE
      • 7.3.4.1. Valve for life (VFL) initiative
    • 7.3.5. U.K.
      • 7.3.5.1. Establishment of specialty valve clinics
    • 7.3.6. REST OF EUROPE (ROE)
      • 7.3.6.1. Rising initiatives and awareness programs in Poland and Portugal
  • 7.4. ASIA-PACIFIC
    • 7.4.1. JAPAN
      • 7.4.1.1. Rising aging population
      • 7.4.1.2. Favorable reimbursement scenario
      • 7.4.1.3. Dilution of regulatory stringency
    • 7.4.2. CHINA
      • 7.4.2.1. Rising aging population and prevalence of valvular heart diseases in china
      • 7.4.2.2. Unfavorable reimbursements
    • 7.4.3. INDIA
      • 7.4.3.1. High patient pool for target diseases
      • 7.4.3.2. State government funded insurance schemes
    • 7.4.4. REST OF ASIA-PACIFIC (ROAPAC)
      • 7.4.4.1. Growing medical tourism in Asian countries
  • 7.5. REST OF THE WORLD
    • 7.5.1. RISE IN AGING POPULATION
    • 7.5.2. HIGH PREVALENCE OF HEART VALVE DISEASE IN BRAZIL
    • 7.5.3. FAVORABLE MEDICAL TOURISM DESTINATION

8. COMPETITIVE LANDSCAPE

  • 8.1. MARKET SHARE ANALYSIS (2016)
    • 8.1.1. INTRODUCTION
    • 8.1.2. GLOBAL TRANSCATHETER HEART VALVES MARKET SHARE, BY KEY PLAYER, 2016
    • 8.1.3. GLOBAL TISSUE HEART VALVES MARKET SHARE, BY KEY PLAYER, 2016
    • 8.1.4. GLOBAL MECHANICAL HEART VALVES MARKET SHARE, BY KEY PLAYER, 2016
    • 8.1.5. EDWARDS LIFESCIENCES CORPORATION
    • 8.1.6. MEDTRONIC PLC
    • 8.1.7. ST. JUDE MEDICAL, INC.
  • 8.2. VENDOR DIVE OVERVIEW
    • 8.2.1. VANGUARDS
    • 8.2.2. INNOVATOR
    • 8.2.3. DYNAMIC
    • 8.2.4. EMERGING
  • 8.3. COMPETITIVE BENCHMARKING
    • 8.3.1. ANALYSIS OF PRODUCT PORTFOLIO OF MAJOR PLAYERS IN THE PROSTHETIC HEART VALVE MARKET (18 PLAYERS)
    • 8.3.2. BUSINESS STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE PROSTHETIC HEART VALVE MARKET (18 PLAYERS)

Top 13 companies analysed for this study are - Edwards Lifesciences Corporation (U.S.), Medtronic plc (Ireland), St. Jude Medical, Inc. (Abbott Laboratories Company) (U.S.), Boston Scientific Corporation (U.S.), LivaNova PLC (U.K.), Symetis SA (Switzerland), JenaValve Technology, Inc. (Germany), CryoLife, Inc. (U.S.), TTK Healthcare Limited (India), Colibri Heart Valve, LLC (U.S.), Lepu Medical Technology Co., Ltd. (China), and Braile Biomedica (Brazil). Other players in this market include Micro Interventional Devices, Inc. (U.S.), Autotissue Berlin GmbH (Germany), Comed B.V. (Netherlands), Meril Life Sciences Pvt. Ltd. (India), Labcor Laboratorios Ltda. (Brazil), and HLT Inc. (A Bracco Group Company) (U.S.)

9. COMPANY PROFILES (Overview, Products and Services, Financials, Strategy & Development)*

  • 9.1. INTRODUCTION
  • 9.2. MEDTRONIC PLC
  • 9.3. EDWARDS LIFESCIENCES CORPORATION
  • 9.4. BOSTON SCIENTIFIC CORPORATION
  • 9.5. LIVANOVA PLC
  • 9.6. ST. JUDE MEDICAL, INC. (AN ABBOTT LABORATORIES COMPANY)
  • 9.7. SYMETIS SA
  • 9.8. JENAVALVE TECHNOLOGY, INC.
  • 9.9. CRYOLIFE, INC.
  • 9.10. TTK HEALTHCARE LIMITED (A TTK GROUP COMPANY)
  • 9.11. COLIBRI HEART VALVE, LLC
  • 9.12. LEPU MEDICAL TECHNOLOGY CO., LTD.
  • 9.13. BRAILE BIOMEDICA

*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.

10. APPENDIX

  • 10.1. DISCUSSION GUIDE
  • 10.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 10.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 10.4. AVAILABLE CUSTOMIZATIONS
  • 10.5. RELATED REPORTS
  • 10.6. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: GLOBAL PROSTHETIC HEART VALVES MARKET SNAPSHOT
  • TABLE 2: GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE OF VALVE, 2015-2022 (USD MILLION)
  • TABLE 3: GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE OF VALVE, 2015-2022 (UNITS)
  • TABLE 4: GLOBAL TRANSCATHETER HEART VALVES MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 5: GLOBAL TRANSCATHETER HEART VALVES MARKET SIZE, BY REGION, 2015-2022 (UNITS)
  • TABLE 6: NORTH AMERICA: TRANSCATHETER HEART VALVES MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 7: NORTH AMERICA: TRANSCATHETER HEART VALVES MARKET SIZE, BY COUNTRY, 2015-2022 (UNITS)
  • TABLE 8: EUROPE: TRANSCATHETER HEART VALVES MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 9: EUROPE: TRANSCATHETER HEART VALVES MARKET SIZE, BY COUNTRY, 2015-2022 (UNITS)
  • TABLE 10: ASIA-PACIFIC TRANSCATHETER HEART VALVES MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 11: ASIA-PACIFIC: TRANSCATHETER HEART VALVES MARKET SIZE, BY COUNTRY, 2015-2022 (UNITS)
  • TABLE 12: GLOBAL TISSUE HEART VALVES MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 13: GLOBAL TISSUE HEART VALVES MARKET SIZE, BY REGION, 2015-2022 (UNITS)
  • TABLE 14: NORTH AMERICA: TISSUE HEART VALVES MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 15: NORTH AMERICA: TISSUE HEART VALVES MARKET SIZE, BY COUNTRY, 2015-2022 (UNITS)
  • TABLE 16: EUROPE: TISSUE HEART VALVES MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 17: EUROPE: TISSUE HEART VALVES MARKET SIZE, BY COUNTRY, 2015-2022 (UNITS)
  • TABLE 18: ASIA-PACIFIC: TISSUE HEART VALVES MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 19: ASIA-PACIFIC: TISSUE HEART VALVES MARKET SIZE, BY COUNTRY, 2015-2022 (UNITS)
  • TABLE 20: GLOBAL MECHANICAL HEART VALVES MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 21: GLOBAL MECHANICAL HEART VALVES MARKET SIZE, BY REGION, 2015-2022 (UNITS)
  • TABLE 22: NORTH AMERICA: MECHANICAL HEART VALVES MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 23: NORTH AMERICA: MECHANICAL HEART VALVES MARKET SIZE, BY COUNTRY, 2015-2022 (UNITS)
  • TABLE 24: EUROPE: MECHANICAL HEART VALVES MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 25: EUROPE: MECHANICAL HEART VALVES MARKET SIZE, BY COUNTRY, 2015-2022 (UNITS)
  • TABLE 26: ASIA-PACIFIC: MECHANICAL HEART VALVES MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 27: ASIA-PACIFIC: MECHANICAL HEART VALVES MARKET SIZE, BY COUNTRY, 2015-2022 (UNITS)
  • TABLE 28: GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 29: GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY REGION, 2015-2022 (UNITS)
  • TABLE 30: NORTH AMERICA: PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 31: NORTH AMERICA: PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2015-2022 (UNITS)
  • TABLE 32: NORTH AMERICA: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 33: NORTH AMERICA: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE, 2015-2022 (UNITS)
  • TABLE 34: MEDICARE NATIONAL AVERAGE COVERAGE FOR HEART VALVE REPLACEMENT PROCEDURES
  • TABLE 35: U.S.: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 36: U.S.: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE, 2015-2022 (UNITS)
  • TABLE 37: CANADA: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 38: CANADA: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE, 2015-2022 (UNITS)
  • TABLE 39: EUROPE: PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 40: EUROPE: PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2015-2022 (UNITS)
  • TABLE 41: EUROPE: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 42: EUROPE: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE, 2015-2022 (UNITS)
  • TABLE 43: GERMANY: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 44: GERMANY: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE, 2015-2022 (UNITS)
  • TABLE 45: FRANCE: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 46: FRANCE: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE, 2015-2022 (UNITS)
  • TABLE 47: U.K.: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 48: U.K.: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE, 2015-2022 (UNITS)
  • TABLE 49: ROE: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 50: ROE: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE, 2015-2022 (UNITS)
  • TABLE 51: ASIA-PACIFIC: PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 52: ASIA-PACIFIC: PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2015-2022 (UNITS)
  • TABLE 53: ASIA-PACIFIC: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 54: ASIA-PACIFIC: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE, 2015-2022 (UNITS)
  • TABLE 55: JAPAN: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 56: JAPAN: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE, 2015-2022 (UNITS)
  • TABLE 57: CHINA: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 58: CHINA: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE, 2015-2022 (UNITS)
  • TABLE 59: INDIA: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 60: INDIA: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE, 2015-2022 (UNITS)
  • TABLE 61: ROAPAC: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 62: ROAPAC: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE, 2015-2022 (UNITS)
  • TABLE 63: ROW: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 64: ROW: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE, 2015-2022 (UNITS)

LIST OF FIGURES

  • FIGURE 1: GLOBAL PROSTHETIC HEART VALVES MARKET SEGMENTATION
  • FIGURE 2: GLOBAL PROSTHETIC HEART VALVES MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 3: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 4: PRIMARY RESEARCH - CURRENT SAMPLING FRAME
  • FIGURE 5: BREAK DOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 6: MARKET SIZE ESTIMATION METHODOLOGY: GLOBAL MARKET
  • FIGURE 7: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH FOR THE TRANSCATHETER HEART VALVES MARKET
  • FIGURE 8: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH FOR THE TISSUE HEART VALVES MARKET
  • FIGURE 9: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH FOR THE MECHANICAL HEART VALVES MARKET
  • FIGURE 10: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH FOR THE GLOBAL PROSTHETIC HEART VALVES MARKET
  • FIGURE 11: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 12: DATA TRIANGULATION METHODOLOGY
  • FIGURE 13: TRANSCATHETER HEART VALVES SEGMENT TO REGISTER THE HIGHEST CAGR FROM 2017 TO 2022
  • FIGURE 14: NORTH AMERICA TO REGISTER THE HIGHEST CAGR IN THE FORECAST PERIOD
  • FIGURE 15: EVOLUTION OF PROSTHETIC HEART VALVES
  • FIGURE 16: RISING PREVALENCE OF HEART VALVE DISEASE IS ONE OF THE MAJOR FACTORS DRIVING THE GROWTH OF THE PROSTHETIC HEART VALVES MARKET
  • FIGURE 17: TRANSCATHETER HEART VALVES TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 18: NORTH AMERICA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 19: GLOBAL PROSTHETIC HEART VALVES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGE
  • FIGURE 20: GLOBAL PROSTHETIC HEART VALVES MARKET, BY TYPE OF VALVE
  • FIGURE 21: TRANSCATHETER HEART VALVES SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 22: NORTH AMERICA: PROSTHETIC HEART VALVES MARKET SNAPSHOT
  • FIGURE 23: EUROPE: PROSTHETIC HEART VALVES MARKET SNAPSHOT
  • FIGURE 24: ASIA-PACIFIC: PROSTHETIC HEART VALVES MARKET SNAPSHOT
  • FIGURE 25: ROW: PROSTHETIC HEART VALVES MARKET SNAPSHOT
  • FIGURE 26: VENDOR DIVE COMPARISON MATRIX: PROSTHETIC HEART VALVES MARKET
  • FIGURE 27: PRODUCT MIX OF KEY PLAYERS IN MARKET
  • FIGURE 28: MEDTRONIC PLC: COMPANY SNAPSHOT (2015)
  • FIGURE 29: EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2016)
  • FIGURE 30: BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2016)
  • FIGURE 31: NEOVASC INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 32: LIVANOVA PLC: COMPANY SNAPSHOT (2016)
  • FIGURE 33: ST. JUDE MEDICAL, INC. (AN ABBOTT LABORATORIES COMPANY): COMPANY SNAPSHOT (2015)
  • FIGURE 34: CRYOLIFE, INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 35: TTK HEALTHCARE LIMITED: COMPANY SNAPSHOT (2015)
Back to Top